Rare diseases, orphan drugs, and their regulation in Asia: Current status and future perspectives
スポンサーリンク
概要
- 論文の詳細を見る
Rare diseases are an important public health issue and a challenge to medical care. Specific legislation to encourage research of rare diseases and development of orphan drugs has been adopted in the United States (US), the European Union (EU), and elsewhere. In recent years, much progress has been made in some parts of Asia, including Japan, South Korea, and Taiwan, with the enactment of legislation and accompanying regulation of rare diseases and orphan drugs. China is also actively promoting the regulation of rare diseases and orphan drugs. We describe the current status of the regulation of rare diseases and orphan drugs in Asia and we comparatively analyze the regulation of rare diseases and orphan drugs worldwide in order to examine the challenges to and future perspectives on promoting research on rare diseases and development of orphan drugs in China and other Asian countries.
- 特定非営利活動法人 バイオ＆ソーシャル・サイエンス推進国際研究交流会の論文
著者
-
Inagaki Yoshinori
Department Of Surgery Jikei University School Of Medicine
-
Tang Wei
Department Of Anatomy Showa University School Of Medicine
-
KOKUDO Norihiro
Department of Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, University of Tokyo
-
Inagaki Yoshinori
Department of Surgery, Graduate School of Medicine, the University of Tokyo
-
Song Peipei
Department of Surgery, Graduate School of Medicine, the University of Tokyo
-
Gao Jianjun
Department of Surgery, Graduate School of Medicine, the University of Tokyo
関連論文
- Identification of genes preferentially methylated in hepatitis C virus-related hepatocellular carcinoma
- Surgery for multiple hepatic colorectal metastases
- An Optimized Yeast Cell-Free System : Sufficient for Translation of Human Papillomavirus 58 L1 mRNA and Assembly of Virus-like Particles(GENETICS, MOLECULAR BIOLOGY, AND GENE ENGINEERING)
- Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan
- Disruption of Actin Filaments by Latrunculin B Affects Cell Wall Construction in Picea meyeri Pollen Tube by Disturbing Vesicle Trafficking
- Hepatic encephalopathy caused by congenital extrahepatic portosystemic venous shunt
- Evidence-Based Clinical Practice Guidelines for Hepatocellular Carcinoma in Japan : the J-HCC Guidelines
- Hepatic parenchymal transection using ultrasonic coagulating shears : a preliminary report
- Aging process of the human lumbar spinal cord: A morphometric analysis
- Demonstration of quality of care measurement using the Japanese liver cancer registry
- Rare diseases, orphan drugs, and their regulation in Asia: Current status and future perspectives
- Prediction of macroscopic findings of hepatocellular carcinoma on hepatobiliary phase of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging: Correlation with pathology
- Regulation of the catalytic domain of protein phosphatase 1 by the terminal region of protein phosphatase 2B